The increase in price target from $145 to $170 by UBS analyst Peter Grom, while maintaining a Neutral rating, suggests a positive outlook on Clorox's stock price in the short term. This adjustment reflects an expectation of improved performance or valuation metrics for Clorox, which could lead to increased investor interest and potentially a rise in stock price.